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Guinea pig neutrophils contain the antimicrobial cationic pcptides GNCP-I and GNCP-2 in the grander,, In this study, the GNCP gene was isolated, 
and the struclure was characterized. Using cDNA probes. one phage clone was isolated from a guinea pig genomic library. The gene spanned ~3 
kb, and comprised three exons. and two introns. Sequence analysis revealed that the gene encoded GNCP-2. Exon 1 tnainly coded for the 5 
untranslated region, cxon 2 coded for the prcpro-pcptide region of GNCP-2, and exon 3 coded for the mature peptide region of GNCP-2 and the 
3’ untrans!ated region. Primer extension analysis indicated that the transcription initiation site was located to a thymidine residue, 93 bp upstream 
of the ATG initiation codon of GNCP-2 mRNA. A possible TATA box was located 24 bp upstream of the transcription start site. Interestingly. 
the pyrimidine-rich sequences identiiied in the promoter egions of the human ncutrophil elastasc and myclaperoxidase g nes were also found in 
the 5’ flanking region of the GNCP-2 gene. 
Neutrophil cationic peptidc; Antimicrobial peptide; Gene structure: Primer extension; Guinea pig 
1. INTRODUCTION 
Neutrophils play a central role in protecting hosts 
against he microbial infection. Both oxidative and non- 
oxidative mechanisms are used by neutrophils to restrict 
infection [l-3]. Molecules such as H201, Oi and HOC1 
are examples of microbicidal agents that are derived 
from oxidative metabolism [1,3]. On the other hand, 
neutrophil granules contain antimicrobial proteins and 
peptides that contribute to the oxygen-independent host 
defense mechanism [2,3-J. The most abundant of these 
antimicrobial components are low molecular-weight 
cationic peptides with potent microbicidal activities 
against bacteria, fungi and viruses [2-7-J. In addition, the 
cationic peptides have been shown tu display cytotoxic 
and histamine-releasing activities [5,7]. 
Recently we have purified the two cationic peptides 
GNCP- 1 and GNCP-2 from guinea pig ncutrophils, and 
found that GNCP-1 and GNCP-2 are single-chain pep- 
tides comprising 31 amino acid residues, which differ 
only by the substitution of an isoleucine (GNCP-1) for 
a leucine (GNCP-2) at position 21 [7]. Furthermore, we 
have isolated the cDNA clones for GNCPs, and shown 
that transcription of the GNCP gene and expression of 
GNCP mRNA are observed in bone marrow cells, but 
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not in mature neutrophils [8]. Thus, the expression of 
the GNCP gene appears to be restricted to the maturing 
neutrophils in the bone marrow. However, the mecha- 
nism(s) controlling GNCP gene expression during neu- 
trophil maturation is not clear. In this study, therefore, 
to b&gin to understand the regulation of the GNCP gene 
expression, we have isolated the genomic clone for 
GNCP and determined the gene structure. 
2. MATERIALS AND METHODS 
2. I. Screening of rite guineu pig genomic DNA fibrury 
A guinea pig genomic DNA library was constructed with partial 
Suu3Al digests of guinea pig liver DNA and the cloning vector 
EMBLB (Promega), according to the manufactu&s instructions, 
Two million clones were plated on Eschcrichiu coli strain LE392, and 
screened by plaque hybridization [9], using GNCP-I and GNCP-2 
cDNAs as probes [8]. The probes were labeled with [u-‘*P]dCfP (3000 
Ciimmol, Amersham) using random hexanucleotidc primers 
(Prom+) [IO]. Positive plaques were subjected to a second and third 
screening to isolate single plaques. Phagc DNA was purified by the 
standard method of ccsium chloride step gradient centrifugation [9]. 
2.2. Reswiclion endonucleuse mapping of/he genomic DNA clorre 
Phage DNA was digested with one or more restriction endonu- 
clcases and the resulting fragments were separated by aprose (1%) gel 
clectrophoresis, dcnatuFed inalkali, and transferred to a nylon mcm- 
brane (Hybond.N, Amersham) as described by Southern [l I]. Filters 
were hybridixd with “P-labeled GNCP-I and GNCP-2 cDNA 
probes. and the sizz of the fragments containing exons were deter- 
mined. The phage DNA was ntso mapped by the method of Rackwitz 
et al. [ 121, using partial restriction rndonucleasc digests of the phage 
DNA and ‘2P-lat&d synthetic 12.base oligonucleotides complemen- 
tary to the eos sites of the phagc DNA. The oligonucleotides were 
labeled with [$*P]ATP (6000 Cifmmol, Du PontINEN) at the S’ end 
by T4 polynuclcotidc kinase (Promcga). 
2.3. Subcfoning and DNA sequencing 
Selected restriction fragments of the genomic DNA insert were 
subcloned into the plasmic vector Bluescript SK (-) (Stratagene). The 
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nuclcotide sequences of the DNA fragments were determined from 
both directions with sequence specific oligonucleotide primers by the 
dideoxy chain-termination procedure [13], using the Sequenasc DNA 
Sequencing Kit (United States Biochemical), o: the Taq Dye Deoxy 
Terminator Cycle Sequencing Kit and the 373A DNA Sequencer (Ap- 
plied Biosyslems). 
2.4. Mapping fire 5’ cttd OJ the GNCP tnRNA 
The location OS the 5’ end of the GNCP mRNA was identified by 
primer extension analysis [141. Total cellular RNA was isolated from 
bone marrow cells by the guanydinium thiocyanate extraction method 
[I 51, and poly(A)’ RNA was selected by oligo-dT cellulose column 
chromatography (Collaborative Research). The oligonucleotide 
printer (5’.GGTCTCAAGAGGCA-3’) which was specific for GNCP- 
2 mRNA and complementary tonucleotidcs +l I to +24 of the GNCP- 
2 gene sequence (numbered according to Fig. 2). was labeled with 
[y-‘*P]ATP (6000 Ci/mmol, Du Pont/NEN) using T4 polynucleotide 
kinase. The labeled primer (2 x IO’cpm) was mixed with poly(A)’ (10 
~8) in 10 mM Tris-HCI, pH 8.3,250 mM KCI and I mM EDTA (tolal 
volume 2Oyl), heoted to 60°C for I h, and then allowed to anneal at 
room temperature for I.5 h. The reverse transcriptase reaction was 
performed in 20 mM Tris-HCI, pH 8.3.75 mhd KCI, IO mM M&t,, 
10 mM dithiothreitol. 0.25 mM EDTA, 0.25 mM dNTPs. 50 yg/ml 
actinomycin D and IO U&l M-MLV reverse transcriptase (Bethesda 
Research Laboratories) (total volume SO ~1) at 37’C for 1 h. After 
extraction with phenol/chloroform and ethanol precipitation, the 
products were separated on a 6% polyacrylamide, 8 M urea sequcnc- 
ing gel. The sequencing ladders were generated by the dideoxy chain- 
tertnina!ion method utilizing the same oligonucleotide primer agains 
the genomic DNA fragment, and used as size markets, 
3. RESULTS AND DISCUSSION 
3.1. Cloning and sequencing of the GNCP gene 
By screening the guinea pig genomic library (2 x 106 
independent clones) with the 32P-labeled GNCP-1 and 
GNCP-2 cDNA probes, one hybridizing phage clone 
was identified, containing a 14 kb DNA insert. Restric- 
tion enzyme mapping by Southern analysis using the 
cDNA probe indicated that the exons of the GNCP 
genes dispersed over a 3 kb region (Fig. 1A). Then, the 
3.2 kb HirtdIII-BarnHI fragment was completely se- 
quenced (Fig. IB and Fig. 2), and the sequence was 
compared to the previously published cDNA sequences 
for GNCP-1 and GNCP-2 (accession umbers X57705 
and X63676, respectively, for DDBS/EMBL/GenBank) 
[8]. The gene proved to code for GNCP-2 cDNA: the 
gene encoded Gin’* and Leu2’ of GNCP-2, compared 
to Gluc8 and Iie” of GNCPc1 [7,8]. The gene was com- 
posed of three exons interrupted by two introns. Each 
splice site agreed with the consensus sgiice site se- 
quences in that the 5’ end of the intron began with the 
dinucleotide GT, and the 3’ end finished with the dinu- 
cleotide AG preceded by a pyrimidine rich sequence 
[ 16,171. The length of each exon varied from 80 bp (exon 
1) to 227 bp (exon 3). The length of the intron was 1217 
bp between exon 1 and exon 2, and 561 bp between exon 
2 and exon 3. The single, in-frame start codon for trans- 
lation (Metd6’) was located in exon 2, and the single, 
in-frame stop codon (TAA) was located in exon 3. Exon 
1 coded mainly the 5’ untranslated region, exon 2 
mainly coded for consensus sequence for translation 
initiation [18] and the prepro-peptide region, and exon 
3 mainly encoded the mature peptide region and the 3’ 
cntranslated region. The gene ended with a polyadenyl- 
ation signal and a site for poly (A) addition I5 bp 3’ to 
the signal. 
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Fig. ! , Res:riction map and schematic structure of the CNCP-2 gene. (A) Diagram of the GNCPZ gw. Restrllioil sites ~d exons were drlcrmined 
with the 14 kb SufI fragment insert of the phage clone obtained from the size-fractionated EMBL3 genomic library. Exons are shown by the 
numbered boxes. Filled areas indicate lhe coding regions and open areas depict the 5’ and 3’ untranslated regions of the GNCP-2 mRNA. (B) 
Diagram of the 3205 bp H/ndlII-BnmHI segment of the cloned genomic DNA that was completely sequenced. Horizontal arrows indicale the 
direction and length of sequencing reactions from the specific primers. 
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3.2. Characterizarion of he rranscription initiation site 
and rke prornotor region 
The transcription initiation site of the GNCP-2 gene 
was determined by primer extension analysis. Using 
poly(A)’ RNA from bone marrow cells, one predomi- 
nant primer extension product was observed (Fig. 3A). 
The extension product was aligned with sequencing lad- 
ders produced by dideoxy sequencing of the genomic 
clone using the same primer, and the major transcrip- 
tion start site was localized to a thymidine residue 10 bp 
upstream of the primer and 93 bp upstream of the initi- 
ation codon (ATG) of GNCP-2 mRNA. 
Examination of the sequence of the 5’ flanking region 
revealed the presence of a TATA-like sequence 
(TAAATAT) at nucleotide -24 and two CAAT-like 
sequences at nucleotides -8s and -132 (Fig. 2). A glu- 
cocorticoid responsive element-like sequence 
(AAGACAGGAAGTCCT vs. AGAACANNNTG- 
TI’CT [19]) was also found upstream of the TATA box 
at - 179 to -165. Interestingly, in a preliminary experi- 
ment the GNCP gene transcription rate analyzed by a 
transcription run-off assay [8] was observed to be up- 
regulated 2- to 3-fold by treatment of the bone marrow 
cells with 10 @ml dexamethasone (not shown). 
The transcription of the genes for neutrophil granule 
components, such as elastase, myeloperoxidase, and 
cationic peptide, is suggested to be limited to a period 
of neutrophil maturation that takes place in the bone 
marrow [8,20-231. In the 5’ flanking regions of the 
human neutrophil elastase and myeloperoxidase genes, 
pryrimidine-rich sequences (CCCCTTCTCCCCCT- 
TTTCA for the neutrophil elastase gene and CCCCT- 
TCCCCCCATTTCA for the myeloperoxidase gene) 
were identified, and these sequences are assumed to be 
a regulatory clement for the two genes [24-261. Interest- 
ingly, the pyrimidine-rich sequences are also found in 
the 5’ flanking region of the GNCP-2 gene at -67 to -52 
and -473 to -433, although the pyrimidine-rich se- 
quences of the GNCP-2 gene shared at most 60-708 
homology with those of the human neutrophil elastase 
and myeloperoxidase genes. The role of the promotor 
region, including the glucocorticoid responsive lement 
and the pyrimidine-rich sequences in the GNCP gene 
expression remains to be elucidated in the future. 
AtGGCCCbGCCTCACC~TClCCCAAGACCAcMCACCACTCTCACACTAAGA7GAAAGGAGACAGAGAAGACCAtGT~~?GTCATTTettrtteGcrCCrrGAAA~A~ACtCtt~AA 1476 
IelAl~GlnAl~GluProtruProArrAlrAl~A1~H11SorA1pThrLtolslLt~l~A‘PAt1GluA~P~l6~~lA111~lllC5rlPhoTrffilvGlvGlu5orTbr~~lO~Gl~ 
t -AD -30 +!a -IO 
AChAGAACCTGCCCTTlTCCATetCAeCETCteAIECTGGGAACCT~~CTTCCACAAtCGAGTCTACACAT~C7G~~TAACCTT~AGAATAAAAAACAATT~ATIT~GCT~T~G~~ fled 
ThfArsThrCv1Ar‘PhcPr~T~rAr1Ar1L@uGlmThrCt1LouPhcGlnA1nAr‘~~lT~rThrPhnC~6t~~~nd 
IO eo a0 
fAACAEAATTGCTGCTlTCCTGTAGCTATGtCTTCCATTCTTTTCTTT~GTTA~TTG~CTCCAATT~Ills~1llrl~llclLl‘11~~l~Ccls~lI~l~~~~~l1~11~1 ‘2316 
tcDcDlC1PPDDC1OICOc~lclll~l~~‘ncnc~c~~~lcccc~~~~~cl~~~~~I~~I~~~~~~s~cc~cl~~lIc“‘~:ee em 
Fig. 2. The nucleotidc sequences ofthe GNCP-2 gene. The nucleotide sequences arc numbered from the putative tranxription initiation site marked 
with an asterisk. The sequence of the 5’ flanking region is numbered from -1 to -804 starting 5’ to the transcription initiation site. Nuclestides 
comprising exons are in upper-case l tters, and those comprising introns are in lower-ease letters. Far the 5’ flanking region, the putative 
glucocortieoid responsive lement is double.undcrlined; the pyrimidine-rich sequences found in the promotor regions of the human neutrophil 
elastasc [24] and myeloperonidase g nes [25] are underlined; the TATA-like and CAAT-like sequences are boxed. The sequence of the eomplemen- 
tary oliyonuclcotide used in the primer crtension study is underlined in exon I (see Fig, 3). The polyadenylation signal (AATAAA) is underlined 
in the 3’ untranslated region. The 3’ end of exon 3 is deduced from the site for @y(A) addition in the GNCP-2 mRNA. For the ding CXOZZ. 
the deduced amino acid sequences are shown under the nucleotide sequences, and are numbered beginning at the N-terminal residue of the mature 
GNCP-2. Negative numbers (-62 to -I) refer to the putative signal peptide (-62 to -44) and pro-pptide (-43 to -1). The arrows indicate the 
predicted signal peptide and pro-peptidc leavage sites. 
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Fig. 3. Identification of the transcription initiation site for the GNCP-2 gene by primer extension analysis. (A) Primer extension evaluation of bone 
marrow cell mRNA. 3zP-lab&d oligonucleotide primer (2 x II? spm) corresponding to the specific sequence of exon 1 of the GNCP-2 gene shown 
in Fig. 2 and Fig. 3B was annealed to poly(A)* RNA (10 ,ug), and extended by reverse transcriptase. The extended products were analyzed on a 
6% polyacrylamide denaturlug gel. The length of the products was determined by the comparison with sequencing ladders run alongside the 
extension reaction, The arrow indicates the major primer extension product, and the corresponding transcription initiation site is marked with an 
asterisk. The arrowhead indicates the labeled primer. (B) Structures of the GNCP-2 gene and GNCP-2 mRNA. The start codon (ATG), the stop 
codon (TAA) and the poly(A) tail are shown in GNCP-2 mRNA. The filled box indicates the primer, and the corresponding sequence isunderlined 
in the GNCP2 gene. The putative transcription initiation site is marked with an asterisk. 
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